1. Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Tofacitinib
h. Ustekinumab
i. Vedolizumab
2. How many patients were treated in the last 3 months for Crohn’s Disease ONLY with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilars
f. Ustekinumab
g. Vedolizumab

Download response Biologics drugs used in the Gastroenterology department. 081021.docx